AurKa Pharma - Ownership and Business Overview

Life ScienceCompany

AurKa Pharma Ownership

Who owns AurKa Pharma?

AurKa Pharma is owned by Eli Lilly. It was acquired on May 14, 2018.

AurKa Pharma Business Overview

Where is AurKa Pharma headquartered?

AurKa Pharma is headquartered in Montreal, Quebec.

What sector is AurKa Pharma in?

AurKa Pharma is a life science company.

When was AurKa Pharma founded?

AurKa Pharma was founded in 2016.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

AurKa Pharma, Inc.

Montreal, Quebec
Canada,

AurKa Pharma, Inc. is a developer of an oncology compound AK-01. AurKa Pharma was founded in 2016 and is based in Montreal, Quebec.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.